Beranda › Diabetes Tipe 2 › Texas › McKinney
Uji klinis Diabetes Tipe 2 di McKinney, TX
6 studi untuk Diabetes Tipe 2 mencari peserta di lokasi sekitar McKinney (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Menerima pesertaFase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Menerima pesertaSukarelawan sehat diterima
- North Dallas Research Associates - Kerlo Network, McKinney
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Menerima pesertaFase 2
- Sunbeam Clinical Research, McKinney
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Menerima pesertaFase 3
- Research Site, McKinney
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Menerima peserta
- Tekton Research, McKinney
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Menerima pesertaFase 2
- Tekton Research, McKinney
Uji klinis Diabetes Tipe 2 di kota lain
- San Antonio, TX37 studi
- Houston, TX31 studi
- Orlando, FL24 studi
- Boston, MA20 studi
- Miami, FL19 studi
- Chicago, IL19 studi
- Dallas, TX19 studi
- Columbus, OH18 studi
- Las Vegas, NV18 studi
- Atlanta, GA17 studi
- San Diego, CA17 studi
- Los Angeles, CA16 studi
Studi lain di McKinney
- Gagal Jantung7 studi
- Asma5 studi
- PPOK5 studi
- Penyakit Ginjal Kronis4 studi
- Penyakit Kardiovaskular4 studi
- Obesitas4 studi
- Aterosklerosis3 studi
- Penyakit Paru Interstisial3 studi
- Penyakit Graves3 studi
- Fibrilasi Atrium3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.